Bailisi Kang Biomedicine (Hangzhou)

Bailisi Kang Biomedicine (Hangzhou)


Launch date
Market cap
-
Enterprise valuation
CAD75—113m (Dealroom.co estimates Jan 2023.)
小营街道 Zhejiang (HQ)

  • Edit
DateInvestorsAmountRound

N/A

Series B
*

CNY100m

Series B
*

N/A

Series B
Total FundingCAD18.8m

Recent News about Bailisi Kang Biomedicine (Hangzhou)

Edit